Form 4: Merck Director Thomas Glocer Reports Acquisition of Phantom Stock Units

Thomas Glocer, a director at Merck & Co., Inc., reported the acquisition of phantom stock units settled in cash, according to a recent SEC Form 4 filing.

Summary

• On May 31, 2024, Thomas H. Glocer, a director of Merck & Co., Inc., reported a transaction involving phantom stock.
• Glocer acquired 1,752.4295 units of phantom stock at a price of $125.54 per unit.
• These phantom stock units will be settled 100% in cash upon Glocer's termination of service, following a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Following the reported transaction, Glocer beneficially owns 95,669.3558 derivative securities.
• Glocer also disposed of 5,100 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The phantom stock units will be settled 100% in cash upon the reporting person's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by SEC regulations. It provides transparency into the trading activities of key personnel within Merck.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activities.

Key Dates